NSEDisclosure under SEBI Takeover Regulations22 Jun 2026
Medicamen Biotech Limited
Disclosure under SEBI Takeover Regulations
Medicamen Biotech Limited has submitted its annual disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This filing, made by the promoter Shivalik Rasayan Limited, covers the year ended March 31, 2026. It is a routine compliance submission to the exchanges.
Read more →📎 1 attachment